This disclosure generally relates to fluid delivery devices for delivering therapeutic agents. More particularly, this disclosure relates to drug reconstitution devices having a plurality of components movable with respect to one another such that an active agent and a solvent can be reconstituted within the device prior to injection.
Reconstitution is the process of mixing a lyophilized active agent with a solvent so the active agent can be re-liquefied, or reconstituted, before injection. The process is common, since lyophilizing (or freeze-drying) an active agent, such as a drug, biologic, or other therapeutic, can help to preserve the shelf life of the agent and enable the agent to be delivered to the end user for future mixing. That said, many times the mixing of the agent is expected to be completed by someone other than the manufacturer or a pharmacist, so care must be taken to ensure that the mixing of the solvent and the active agent is accurate and error-proof.
Prior designs for reconstitution devices included a multi-stopper cartridge that housed the solvent between two stoppers and the active agent between the distal of the stoppers and the end of the cartridge. In these designs, the proximal stopper moves axially, pushing the solvent through the distal stopper such that it flows into the space of the cartridge storing the active agent. Once the solvent interacted with the lyophilized agent, the cartridge can be shaken to reconstitute the therapeutic agent. Although prior designs provide a technique to ensure accurate amounts of solvent and active agent were provided in the same cartridge, they do not provide a multitude of redundancies and safety protocols to ensure (1) they were properly mixed and (2) they were properly administered to the patient after mixing. There is therefore a need for improved methods, devices, and systems that accurately reconstitute lyophilized active agents while also providing an error-preventing, integrated apparatus that can be used to administer the reconstituted agent.
It is an object of the present disclosure to provide systems, devices, and methods to reconstitute an active agent while also providing redundancies and feedback to ensure accurate dosing.
The present disclosure provides a fluid delivery device. The fluid delivery device can include a housing including an internal thread. The fluid delivery device can include a cartridge holder mechanically coupled to the housing. The cartridge holder can include an external thread extending at least partially along a length of the cartridge holder. At least a portion of the external thread can wrap 360° around the cartridge holder. The fluid delivery device can include a cartridge disposed within a cartridge holder internal cavity. The fluid deliver device can include a button rod. The button rod can include a retaining hook, a demounting stop extending at a non-zero angle from a longitudinal axis of the button rod, a holding snapper, a bypass snapper extending at a non-zero angle from the longitudinal axis of the button rod, and a drive button.
The housing can include a button rod groove, and the button rod can include a wing sized to engage the button rod groove. A first length of the button rod between the wing and a distal end of the button rod (e.g., a dosage length) can correspond to a volume of fluid expelled from the fluid delivery device.
The fluid delivery device can include a foot coupled to a distal end of the button rod. The foot can include a pusher to push against stoppers in the cartridge. The foot can include a plurality of flexible fingers radially arranged around a common axis extending along the length of the foot.
The cartridge holder can have an extended configuration and a retracted configuration with respect to the housing. In the extended configuration, each flexible finger of the plurality of flexible fingers can engage a proximal end of the cartridge. In the retracted configuration, each flexible finger of the plurality of flexible fingers can engage an internal surface of the cartridge. In the retracted configuration, the demounting stop can abut a housing stop positioned proximate a proximal end of the housing.
The foot can include a foot groove sized to engage a foot snap of the button rod. The foot can be detachably attachable to the distal end of the button rod.
The cartridge holder can be rotatable with respect to the housing. The retaining hook can be inwardly deflectable by the proximal end of the cartridge holder. The housing can include a holding snapper aperture sized to engage the holding snapper.
The internal thread can wrap at least 360° around an interior surface of the housing. The internal thread can wrap at least 420° around an interior surface of the housing. The internal thread can include a beveled first end and a beveled second end to reduce friction as the cartridge holder rotates with respect to the housing.
The housing can include an axial stop sized to engage a proximal end of the cartridge holder. The cartridge holder can have an extended configuration and a retracted configuration with respect to the housing. The axial stop can be positioned to inhibit the cartridge holder from sliding proximally beyond a predetermined position, thereby reducing the chance or likelihood of underdosing.
The cartridge can include a distal tip, a first stopper, a second stopper disposed between the distal tip and the first stopper, an active agent disposed between the distal tip and the second stopper, and a solvent disposed between the second stopper and the first stopper. The fluid delivery device can include a foot coupled to a distal end of the button rod and including a pusher and a plurality of flexible fingers extending radially from the foot and centering the pusher centrally with respect to the first stopper. The fingers can reduce friction as the foot slides distally through the cartridge by centering the pusher. The fingers can also improve dose volume consistency by centering the pusher with respect to the stoppers. The pusher can abut the first stopper when the fluid delivery device is in a resting (e.g., extended) configuration. The active agent can include lyophilized teduglutide.
The cartridge holder can include a radial snap sized and positioned to engage a snap groove in the housing when the cartridge holder is in an extended configuration. Engaging the radial snap with the snap groove can prevent the cartridge holder from rotating inadvertently, for example without the user twisting the device. The radial snap can be sized and positioned to engage a first radial snap aperture and a second radial snap aperture on the housing. Engaging the radial snap with either the first radial snap aperture or the second radial snap aperture radial snap aperture can provide audible and/or tactile feedback of the position of the cartridge holder with respect to the housing (e.g., mixing, priming, etc.).
The cartridge holder can include a radial snap sized and positioned to engage a first radial snap aperture and a second radial snap aperture on the housing. The cartridge holder can be rotatable with respect to the housing from a first position wherein the radial snap engages the first radial snap aperture to a second position wherein the radial snap engages the second radial snap aperture.
A distal end of the cartridge holder can include an internal bevel.
The present disclosure provides a system. The system can include a housing having an internal thread and a button rod groove. The system can include a cartridge holder mechanically coupled to the housing and including an external thread extending at least partially along a length of the cartridge holder and sized to engage the internal thread. The system can include a cartridge disposed within a cartridge holder internal cavity. The system can include a first button rod. The first button rod can include a first drive button and a first wing. A first length of the first button rod between the first wing and a distal end of the first button rod (e.g., a first dosage length) can correspond to a first volume of fluid expelled from the cartridge. The system can include a second button rod. The second button rod can include a second drive button a second wing. A second length of the second button rod between the second wing and a distal end of the second button rod (e.g., a second dosage length) can correspond to a second volume of fluid expelled from the cartridge. The first length can be shorter than the second length, and the first volume can be less than the second volume.
The system can include a foot attachable to a distal end of the first button rod or the second button rod, and the foot can include a pusher to push stoppers within the cartridge. The foot can include a plurality of flexible fingers radially arranged around a common axis extending along the length of the foot. The foot can include a foot groove sized to engage a foot snap of the first button rod or the second button rod.
The above and further aspects of this disclosure are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the disclosure. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
The herein disclosed solution is directed to drug reconstitution devices having a plurality of components movable with respect to one another such that an active agent and a solvent can be reconstituted within the device prior to injection. The plurality of components can provide mechanical, audible, and/or tactile feedback to ensure that the user of the device is properly reconstituting the drug, priming the device for delivery, and injecting the mixed agent. Feedback, safety, and redundancy features are important for drug reconstitution and delivery device for a number of reasons. For one, the drug manufacturer can provide the exact amount of active agent-to-solvent ratio needed for the reconstituted therapeutic. If errors occur during the mixing, this can cause an overdosing or underdosing of the active agent.
Additionally, it is common for the person administering the drug with the delivery device to be someone other than a healthcare provider or pharmacist. These users rely on the device to ensure the mixing is correct and that, once mixed, the accurate amount of drug is delivered. Still further, these devices may be in the hands of people that have dexterity issues, meaning the likelihood of dropping the device may be high. For these reasons, durability and rigidity can be as much of a safety feature as any other feature of the device.
The devices, systems, and methods described herein provide solutions to these problems by providing a fluid delivery system that ensures accurate reconstitution, priming, and delivery. Various devices and methods are disclosed for providing fluid delivery devices, and examples of the devices and methods will now be described with reference to the accompanying figures.
The fluid delivery device 100 can also include a fixed or modular needle cap 110 that includes a needle for delivering the reconstituted liquid to the patient. The needle cap 110 can include internal threads that engage with distal threads 116 on the cartridge holder 102. The fluid delivery device 100 can include a foot 108 to push stoppers within the cartridge to both reconstitute the active agent and to deliver the active agent through the needle cap 110.
As described above, the cartridge 104 can include stoppers to separate the liquid (e.g., solvent) from the powder (e.g., lyophilized active agent). The cartridge 104 can include a first stopper 202 positioned proximal within an internal cavity 132 of the cartridge 104 and a second stopper 204 positioned distal to the first stopper 202. A first reservoir 206 can be positioned between the first stopper 202 and the second stopper 204. The first reservoir 206 can store the solvent used for reconstitution. A second reservoir 208 can be positioned between the second stopper 204 and a distal tip 140 of the cartridge 104. The second reservoir 208 can store the lyophilized active agent. The second stopper 204 can include a plurality of holes or apertures that enable the solvent to leach into the second reservoir 208 when the first stopper 202 is slid axially toward the second stopper 204.
Referring to
Referring to
The foot 108 can include a plurality of flexible fingers 604 extending radially from a longitudinal axis 610 of the foot 108. The flexible fingers 604 can extend to exert a radial force on the interior surfaces of the cartridge holder 102 and the cartridge 104. In this manner, the flexible fingers 604 can ensure central positioning of the pusher 114 with respect to the first stopper 202 as the pusher 114 slides axially though the cartridge 104. The foot 108 can include a pair of flexible fingers 604 (as shown in
In some examples, the foot 108 can be a separate feature from the button rod 250. For example, the foot 108 can be detachably attachable to the distal end 252 of button rod 250. The foot 108 can include foot groove 118 sized to engage a foot snap 253 on the distal end 252 of the button rod 250. The foot snap 253, for example, can be a flange or protrusion on the distal end 252 of the button rod 250, and the foot groove 118 can be an indentation on the foot 108. In this regard, the foot 108 can attachable engage via the foot snap 253 being slide into and aligned with the corresponding groove 118. However, it is contemplated that the foot 108 can be attached to distal end 252 in other approaches, as needed or required. A particular benefit of separating the foot 108 from the button rod 250, as shown and described, includes enabling the two components to rotate and/or flex independently from each other.
The cartridge holder 102 can have an extended configuration and a retracted configuration with respect to the housing 106.
Referring to
The cartridge holder 102 can include a dosage window 306 placed proximate the distal end 312 of the cartridge holder 102. The dosage window 306 can provide a view of the cartridge 104 placed within the cartridge holder 102. The dosage window 306 can be positioned such that the first reservoir 206 and/or second reservoir 208 are visible during reconstitution of the therapeutic. The cartridge holder 102 can also include dosage indicators 317, which can be dots or indentions that illustrate to the user the total dosage volume of the particular injector. For example, a cartridge holder 102 with three dosage indicators 317 (as shown) can correspond to a 0.3 mL dose, and a cartridge holder 102 with four dosage indicators 317 can correspond to a 0.4 mL dose.
The cartridge holder 102 can include a radial snap 308 sized and positioned to engage a snap groove 417 in the housing 106 when the cartridge holder 102 is in an extended configuration. The snap groove 417 can be seen in
Once mixed, the user can continue rotating the cartridge holder 102 with respect to the housing 106 a certain number of turns (e.g., two turns) to prime the fluid delivery device 100 for injection. Once the device is in the fully-primed configuration, the radial snap 308 can engage with a second radial snap aperture 402 (see, e.g.,
The housing 106 can include an axial stop 410 positioned proximate the proximal end 416 of the housing 106. The axial stop 410 can be sized and positioned to engage a proximal end 314 of the cartridge holder 102 when the cartridge holder 102 is in its fully retracted (primed) position. For example, similar to the radial stop 310 described above on the cartridge holder 102, the axial stop 410 can prevent the cartridge holder 102 from retracting beyond a predetermined position. Preventing the cartridge holder 102 from over-retracting into the housing 106 can reduce underdosing.
The housing 106 can include button rod groove 412 positioned proximate the proximal end 416 of the housing 106. The button rod groove 412 can be sized to engage the one or more wings 264 of the button rod 250 to enable the button rod 250 to slide both distally and proximally with respect to the housing 106, while also preventing the button rod 250 from rotating with respect to the housing 106. The button rod groove 412 can have a length that defines the total distance the button rod 250 can travel distally within the housing 106. The button rod groove 412 can be cut into the interior surface 107 of the housing 106 and can accept the one or more wings 264 of the button rod 250. A groove stop 418 can be positioned at the distal end of the button rod groove 412 to confine the wings 264 and prevent the button rod 250 from moving axially beyond the groove stop 418.
Referring to
Providing a plurality of different button rods 250 with varying dosage lengths 280 enables a manufacturer to vary dosages expelled from a fluid delivery device 100 solely by varying the button rod 250 used within the device. For example, the cartridges holders 102, housings 106, foots 108 can all be constant and the same regardless of the dosage for the particular patient. Further, all cartridges 104 can be manufactured with the same volume of solvent and active agent. Depending on the dosage requirement of the patient, however, the button rod 250 can be adjusted to expel more fluid (i.e., a longer dosage length 280) or less fluid (i.e., a shorter dosage length 280).
After injection, any unused fluid can remain in the distal end of the cartridge 104 (i.e., within the second reservoir 208), and the unused fluid (e.g., the entire cartridge 104) can be discarded. Referring to the dosage window 306 on the cartridge holder 102 described above, once the fluid is expelled, the first stopper 202 and second stopper 204 of the cartridge 104 can be viewable within the dosage window 306, and any remaining fluid can be outside of the view of the dosage window 306. This design can prevent patients from attempting to reuse the remaining fluid in the cartridge, since the remaining fluid is obscured from view by the housing 106.
An example use case for varying dosages can include a fluid delivery device for delivering teduglutide, which is a 33-amino acid analog of GLP-2 (glucagon-like peptide 2). Common volume dosages of reconstituted teduglutide include 0.4 mL and 0.3 mL dosages. All cartridges 104 can be pre-filled with enough active agent (teduglutide) and solvent so as to provide a 0.4 mL dose. For patients that only require the 0.3 mL dose, those patients can receive a device having a button rod 250 that has a shorter dosage length 280 (i.e., one designed for 0.3 mL dosages), thereby allowing approximately 0.1 mL of fluid to remain in the cartridge 104 after injection. As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 0.1 mL” may refer to the range of values from 0.0801 mL to 0.1199 mL.
Alternatively or additionally to choosing different button rods 250 based on their dosage length 280, different length foots 108 can be selected for different dosage volumes. As described above, the foot 108 can be attached to the distal end 252 of the button rod 250. To this end, lengthening the foot 108 can also increase the overall length of the device that extends into the cartridge 104, and shortening the foot 108 can also decrease the overall length of the device that extends into the cartridge 104. Further, the foot groove 118 within the foot 108 (e.g., where the distal end 252 of the button rod 250 can attach to the foot 108) can be positioned to alter the overall length of the button rod 250/foot 108 combined device. Selection of the particular button rod 250 and/or foot 108 for a particular dosage volume can be made by a manufacturer, so that the end user only receives the fluid delivery device 100 that is customized for their dosing regimen.
Referring again to
As shown in
In
As described above, the friction of the stoppers 202, 204 within the cartridge 104 can cause the button rod 250 to move axially, as shown in
Examples of the present disclosure can also be implemented according to at least the following clauses:
Clause 1: A method of using the fluid delivery device 100 described above, the method comprising: rotating the cartridge holder 102 with respect to the housing 106 causing the cartridge holder 102 to move axially proximally through the housing 106 from a first position wherein a radial snap 308 on the cartridge holder 102 engages a first radial snap aperture 401 on the housing 106 to a second position wherein the radial snap 308 engages a second radial snap aperture 402 on the housing 106; and rotating the cartridge holder 102 with respect to the housing 106 causes the button rod 250 to move axially distally through the cartridge 104.
Clause 2: The method of clause 1, further comprising: pushing a first stopper 202 distally through the cartridge 104 via a foot 108 coupled to a distal end 252 of the button rod 250 such that the first stopper 202 moves axially distally toward a second stopper 204 within the cartridge 104.
Clause 3: The method of clause 2, wherein the foot 108 is detachably attachable to the distal end 252 of the button rod 250.
Clause 4: The method of clause 2, wherein moving the first stopper 202 axially distally toward the second stopper 204 causes an active agent disposed between a distal tip 140 of the cartridge 104 and the second stopper 204 to mix with a solvent disposed between the second stopper 204 and the first stopper 202, thereby creating a reconstituted liquid.
Clause 5: The method of clause 4, further comprising pressing the drive button 262 axially distally such that the first stopper 202 and the second stopper 204 move axially distally and expel the reconstituted liquid from a distal tip 140 of the cartridge 104.
Clause 6: The method of clause 5, further comprising: expelling only a portion of the reconstituted liquid from the distal tip 140.
Clause 7: The method of clause 6, wherein approximately 0.1 mL of reconstituted liquid remains in the cartridge 104 when the portion of the reconstituted liquid is expelled from the distal tip 140.
Clause 8: The method of clause 4, further comprising engaging the radial snap 308 with the second radial snap aperture 402 thereby causing an audible feedback indicative of the fluid delivery device 100 being primed for injection.
Clause 9: The method of clause 4, wherein the active agent comprises lyophilized teduglutide.
Clause 10: The method of clause 1, further comprising pushing a first stopper 202 distally through the cartridge 104 via a foot 108 coupled to a distal end 252 of the button rod 250 such that the first stopper 202 moves axially distally toward a second stopper 204 within the cartridge 104.
Clause 11: The method of clause 1, further comprising: abutting, with a proximal end 314 of the cartridge holder 102, the demounting stop 254 as the cartridge holder 102 moves axially proximally through the housing 106; and deflecting, with the proximal end 314 of the cartridge holder 102, the retaining hook 256 inwardly such that the retaining hook 256 bypasses a housing stop 702 positioned proximate a proximal end of the housing 106.
Clause 12: The method of clause 11, wherein the step of rotating the cartridge holder 102 with respect to the housing 106 further causes the button rod 250 to move axially with respect to the housing 106 such that the drive button 262 extends from a proximal end 416 of the housing 106.
Clause 13: The method of clause 12, further comprising pushing a first stopper 202 distally through the cartridge 104 via a foot 108 coupled to a distal end 252 of the button rod 250 such that the first stopper 202 moves axially distally toward a second stopper 204 within the cartridge 104, wherein friction of the first stopper 202 sliding within an internal cavity 132 of the cartridge 104 causes the button rod 250 to move axially with respect to the housing 106.
Clause 14: The method of clause 13, pushing, with a proximal end 314 of the cartridge holder 102, the bypass snapper 260 axially proximally with respect to the housing 106.
The descriptions contained herein are examples of embodiments of the disclosure and are not intended in any way to limit the scope of the disclosure. As described herein, the disclosure contemplates many variations and modifications of the aspiration device including using alternative geometries of structural elements, combining shapes and structural elements from various example embodiments, using alternative materials, etc. These modifications would be apparent to those having ordinary skill in the art to which this disclosure relates and are intended to be within the scope of the claims which follow.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/JP2021/044376 | 11/22/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63117538 | Nov 2020 | US |